Navigation Links
NY Pharmacy Bill Sent to Governor Would Raise Drug Prices
Date:12/1/2011

WASHINGTON, Dec. 1, 2011 /PRNewswire-USNewswire/ -- Assembly Bill 5502-B—transmitted to Governor Andrew Cuomo yesterday—would needlessly raise the cost of many prescriptions in New York by 10 percent, according to the Pharmaceutical Care Management Association. If enacted, the Bill would prohibit consumers from getting discounted prescriptions through mail-service pharmacies.

The Federal Trade Commission warns that AB 5502-B will "harm consumers" and "raise prices for, and reduce access to, prescription drugs." And in an editorial, The New York Times says the bill looks like "a favor to retail drug lobbyists that could actually drive up costs for consumers."

"It's wrong for the drugstore lobby to ask Governor Cuomo to sign a bill that enriches them by making businesses and consumers pay more for prescription drugs. Governor Cuomo should veto this bill because employers need every cost saving tool they can get in this economy and mail-service pharmacy is at the top of the list," said PCMA President and CEO Mark Merritt.

Even a lead lobbyist for the bill, Craig Burridge, admits that it could raise costs, telling the New York Times that "drug plans negotiated by labor unions would be exempt from the law if the unions required members to use mail-order pharmacies as a way of saving money."

Mail-service pharmacies offer 90-day prescriptions that are less expensive and more convenient than driving to the drugstore every 30 days. With mail-service pharmacies, patients can get private counseling over the phone from trained pharmacists seven days a week, 24 hours a day. Numerous government and peer-reviewed data have confirmed the incre
'/>"/>

SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Assured Pharmacy Reports Financial Results for the Third Quarter of 2011
2. International Academy of Compounding Pharmacists (IACP) Responds to FDAs Appeal of the U.S. District Court Ruling on Pharmacy Compounding
3. USC School of Pharmacy Establishes International Center for Regulatory Science
4. Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flints Resurgence and Michigans Future
5. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
6. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
7. Innovative Pharmacy Leader Jeanne Ann Stasny Joins Diplomat Specialty Pharmacy as Vice President of Pharmacy Services
8. Study Finds Children More Likely to Receive Recommended RSV Medication Doses When Administered Through Specialty Pharmacy
9. Academy of Managed Care Pharmacy Opens 2011 Educational Conference in Atlanta
10. USC School of Pharmacy to Double Presence in Safety-net Clinics
11. AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... DIEGO , Aug. 26, 2014 Profil ... research organization (CRO) focused on diabetes and obesity, announced ... completion of more than 200 phase I – IIa ... the treatment of type 1 and type 2 diabetes. ... of research is what it represents for the public ...
(Date:8/26/2014)... , Aug. 26, 2014  Ruthigen Inc. (NASDAQ: ... on improving patient outcomes and reducing healthcare costs ... drug candidate, RUT58-60, has received a recommendation from ... patients in the Company,s planned Phase 1/2 clinical ... as an adjunct therapy in combination with prophylactic ...
(Date:8/26/2014)...   Organovo Holdings, Inc. (NYSE MKT: ONVO) ... 3D bioprinting technology, announced today that it has been recognized ... World Economic Forum (WEF) .  Organovo is one ... creativity to design and create transformative solutions. ... Pioneer by the World Economic Forum for the innovation ...
Breaking Medicine Technology:Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 2Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 4Organovo Named 2015 Technology Pioneer by World Economic Forum 2Organovo Named 2015 Technology Pioneer by World Economic Forum 3
... Primary Endpoint, with Positive Effect Sustained Through ... Duration of 4-Week ... VNDA ) (Vanda) today announced positive top-line results from,a Phase III ... agonist, met the primary endpoint,of the trial and significantly improved sleep ...
... with initiatives aimed at knowledge transfer, including landmark ... Massachusetts and the Italian government in ... an innovator and,leader in global patient recruitment for clinical ... of initiatives to make its,quarter-century of expertise more accessible ...
Cached Medicine Technology:Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 2Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 3Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 4Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 5Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 6Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 7Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 8Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 9BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 3BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 4
(Date:8/27/2014)... Georgia (PRWEB) August 27, 2014 ... of PartnerTech AB, a major systems integration and ... Impact Cryotherapy offering the first U.S. designed ... Inc. offered the ideal combination of manufacturing expertise, ... cryotherapy system. Impact Cryotherapy, headquartered in Atlanta, GA, ...
(Date:8/26/2014)... Hearing aids are not always ... plan holders to determine what their hearing care benefits are. ... additional health plans and has published benefit details on their ... , The following is a list of insurances or ... , NYSHIP/ NYS Empire Plan - Hearing Aid Benefit is ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Leelanau ... a fabulous time to visit the region’s wineries. Rolling ... backdrop to wine tasting fun in a weekend event ... Kicking off the festivities is an optional race through ... Vineyards in Suttons Bay. A unique course between rows ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 The ... recipients of the Bruce Simpson Winemaker Scholarship. The ... recipients will each receive $1,000 for the 2014/2015 ... Stemo, Alexis Bogdanova-Hanna and Ashley Nitz. , The ... careers as winemakers and vineyardists in northern Michigan. ...
(Date:8/26/2014)... Charles, LA (PRWEB) August 27, 2014 ... irreversible, it simply makes sense to use hearing ... risk losing hearing forever. There are many different ... and recreational use. Employers generally provide hearing protection ... law enforcement, and other noisy industries. The National ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 3Health News:The Leelanau Peninsula Vintners Association (LPVA) Awards Its First-ever Bruce Simpson Winemakers Scholarships 2Health News:The Hearing Center of Lake Charles Adds a Complete Line of Occupational Hearing Protection Products and Services to Its Offerings 2Health News:The Hearing Center of Lake Charles Adds a Complete Line of Occupational Hearing Protection Products and Services to Its Offerings 3
... N.C. The addition of a chemotherapeutic drug for leukemia ... to enhance the response of certain ovarian cancers to treatment, ... Duke Comprehensive Cancer Center. , "We know that a ... types of cancers, including some ovarian cancers," said Deanna Teoh, ...
... 18 "Getting closer to controlling cancer" requires funding ... of the new federal stimulus, say former White House ... Washington University Medical Center breast cancer laboratory director, ... Denver Post. Weiner, Berg, and former government analyst Paulette ...
... Awareness Month , , SATURDAY, April 18 (HealthDay News) -- ... 200 sites across the United States in May, which ... and children with symptoms such as wheezing, coughing and ... the screenings that will be conducted by allergists. , ...
... (Nasdaq: ISTA ), today announced it will release first ... a conference call to discuss these results and provide a pipeline ... Date: Thursday, May 7, 2009, Time: 5:00 ... Internet: www.istavision.com, Domestic dial-in: 866-356-3377, ...
... PTU can cause liver disease, experts say , , FRIDAY, April ... of the antithyroid drug (PTU) in children has been endorsed ... editor in the April 9 New England Journal of ... liver disease in children and should no longer be used ...
... Perspective HARRISBURG, Pa., April 17 Agriculture ... the first meeting of the Governor,s Food Safety Council on ... The council will meet from 1 p.m. to 4 p.m. ... Harrisburg Area Community College . The council will hear a ...
Cached Medicine News:Health News:Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers 2Health News:Getting Closer to Controlling Cancer Requires Funding More Laboratories and Commitment Beyond Two Years of New Stimulus, Weiner and Berg Assert in Denver Post Oped 2Health News:Group Urges Public to Take Free Asthma Tests in May 2Health News:Drug May Be Dangerous for Kids With Graves' Disease 2Health News:Pennsylvania Governor's Food Safety Council to Hold First Meeting on April 22 2
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: